Zions Bancorporation’s Juno Therapeutics, Inc. JUNO Stock Holding History

Zions Bancorporation’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300	Closed	-$14K	–	769
2017 Q4	$14K	Buy	+300	New	+$15K	﹤0.01%	446

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Zions Bancorporation's JUNO Position: Q1 2018 in Review

Zions Bancorporation sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 300 shares — an estimated $14K sold.

Zions Bancorporation first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $14K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Zions Bancorporation reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Zions Bancorporation sold 300 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $14K.
Zions Bancorporation first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Zions Bancorporation's Juno Therapeutics, Inc. position peaked at $14K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Zions Bancorporation's 13F filing for Q1 2018, filed 3 May 2018.